You are here: Industry Insights > COVID-19

News List

FDA Authorizes First Point-of-Care Antibody Test for COVID-19 americanpharmaceuticalreview
October 09, 2020
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19.
Novacyt signs deal with UK government for COVID-19 testing kits pharmatimes
October 09, 2020
French clinical diagnostics company Novacyt has inked a deal with the UK Department of Health and Social Care (DHSC) for instrument platforms and COVID-19 testing kits.
UK set to produce 70 percent of PPE required domestically by December europeanpharmaceuticalreview
October 09, 2020
Due to the demand caused by the COVID-19 pandemic, the UK government has said British manufacturers will produce the majority of PPE by the end of the year.
Older people likely to be underrepresented in COVID-19 trials, says study europeanpharmaceuticalreview
October 09, 2020
Researchers suggest, based on certain exclusions, older people are likely to be underrepresented in 50 percent of COVID-19 trials and all vaccine trials in the US.
IONTAS and FairJourney Biologics find COVID-19 neutralizing antibodies with picomolar potency expresspharma
September 30, 2020
This viral neutralization efficiency was independently verified by the National Institute for Biological Standards and Control.
First Patient Dosed in DUR-928 Study in COVID-19 Patients with Acute Liver, Kidney Injury americanpharmaceuticalreview
September 30, 2020
DURECT has dosed the first patient in its randomized, double-blind, placebo-controlled, multi-center Phase 2 study to evaluate the safety and efficacy of DUR-928 in hospitalized COVID-19 patients with acute liver or kidney injury.
NeuroRx Submits EUA Request for RLF-100 for COVID-19, Respiratory Failure americanpharmaceuticalreview
September 30, 2020
NeuroRx has submitted a request for an Emergency Use Authorization (EUA) with the FDA for the use of RLF-100? aviptadil in patients who are receiving intensive care and who have exhausted all approved treatments.
COVID-19 Vaccine Prototype for Successfully Induced Systemic Serum IgG in Mice americanpharmaceuticalreview
September 30, 2020
MediciNova announced its intranasal SARS-CoV-2 vaccine prototype for COVID-19, using BC-PIV technology, successfully induced systemic serum IgG and mucosal IgA neutralizing antibodies against the S1 antigen (Ag) of SARS-CoV-2 in mice.
Avigan Shows Promising Results in Treatment of COVID Patients in Japan americanpharmaceuticalreview
September 30, 2020
Global Response Aid (GRA) and Dr. Reddy's Laboratories announced the anti-viral drug Avigan? produced promising results in a single-blinded, placebo-controlled Phase 3 clinical study conducted in Japan with the sponsorship of FujiFilm Toyama Chemical.
First UK patient given GSK’s experimental arthritis drug in COVID-19 trial pharmatimes
September 30, 2020
A patient in Manchester is the first in the UK to be treated in a new COVID-19 trial investigating the use of an experimental arthritis drug, otilimab, for severe lung disease related to the novel coronavirus.